<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Anse Diana Valentiene Messah</style></author><author><style face="normal" font="default" size="100%">Sawitri Darmiati</style></author><author><style face="normal" font="default" size="100%">Cleopas Marthin Rumende</style></author><author><style face="normal" font="default" size="100%">Retno Ariza Soemarwoto</style></author><author><style face="normal" font="default" size="100%">Joedo Prihartono</style></author><author><style face="normal" font="default" size="100%">Asmarinah</style></author><author><style face="normal" font="default" size="100%">Fadilah Fadilah</style></author><author><style face="normal" font="default" size="100%">Aisyah Fitriannisa Prawiningrum</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Prediction of MMP-9 Polymorphism Impacts on MDR-TB by Molecular Simulation and Network Interaction</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Gene polymorphism</style></keyword><keyword><style  face="normal" font="default" size="100%">Matrix metalloproteinase 9</style></keyword><keyword><style  face="normal" font="default" size="100%">Molecular simulation.</style></keyword><keyword><style  face="normal" font="default" size="100%">Multidrug resistant TB</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">833-841</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;MMP-9 overexpression is associated with a poor outcome in MDR-TB patients, indicating that MMP-9 is a suitable target for MDR-TB therapy. MMP-9 also includes SNPs that occur at inhibitor binding areas as well as zinc ions. As a result of polymorphisms, the usage of MMP-9 inhibitors for MDR-TB might vary. Through molecular simulation, it has been found that the mutant MMP-9 has a larger cavity and a more lipophilic surface. The docking tests revealed that EGTA had the least amount of binding energy to both wild-type and mutant MMP-9. The wildtype MMP-9 can bind zinc when EGTA is in the active site. This shows that using EGTA to chelate Zn is only partially successful. However, the binding energy of EGTA at the active site suggests that it may be a competitor to MMP-9 substrates. On the other hand, Zn is not involved in the interaction of the mutant MMP-9-EGTA complex.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Research Article </style></work-type><section><style face="normal" font="default" size="100%">833</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Anse Diana Valentiene Messah&lt;sup&gt;1&lt;/sup&gt;, Sawitri Darmiati&lt;sup&gt;2&lt;/sup&gt;, Cleopas Marthin Rumende&lt;sup&gt;3&lt;/sup&gt;, Retno Ariza Soemarwoto&lt;sup&gt;4&lt;/sup&gt;, Joedo Prihartono&lt;sup&gt;5&lt;/sup&gt;, Asmarinah&lt;sup&gt;1,6,*&lt;/sup&gt;, Fadilah Fadilah&lt;sup&gt;7,*&lt;/sup&gt;, Aisyah Fitriannisa Prawiningrum&lt;sup&gt;8&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Doctoral Program in Biomedical Sciences, Faculty of Medicine University of Indonesia, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Radiology, General Hospital Cipto Mangunkusumo, Faculty of Medicine University of Indonesia, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Internal Medicine Sciences, pulmonology division, Faculty of Medicine, University of Indonesia, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Department of Pulmonology, General Hospital Abdoel Moelok, Faculty of Medicine University of Lampung, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Department of Community Medical Sciences, Faculty University of Indonesia Medicine, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;6&lt;/sup&gt;Departement of Medical Biology, Faculty of Medicine Universitas Indonesia, Jakarta, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;7&lt;/sup&gt;Departement of Medical Chemistry, Faculty of Medicine Universitas Indoensia, Jakarta Indonesia.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;8&lt;/sup&gt;Bioinformatics Core Facilities - IMERI, Faculty of Medicine, Universitas Indonesia, Jakarta, INDONESIA.&lt;/p&gt;
</style></auth-address></record></records></xml>